Effects of topical application of a 2% solution of dorzolamide on intraocular pressure and aqueous humor flow rate in clinically normal dogs

American Journal of Veterinary Research

Volumn 62, Issue 6, 2001, Pages 859-863

  Cawrse, Margaret A ^a,b   Ward, Daniel A ^a   Hendrix, Diane V H ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

^b Akron Veterinary Referral and Emergency Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DORZOLAMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; AQUEOUS HUMOR FLOW; ARTICLE; CONTROLLED STUDY; DOG; FEMALE; FLOW RATE; FLUOROPHOTOMETRY; GLAUCOMA; INTRAOCULAR PRESSURE; MALE; NONHUMAN;

EID: 0034981371     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2001.62.859     Document Type: Article

References (29)

1. Becker B. Decrease in intraocular pressure in man by a carbonic anhydrase inhibitor, Diamox. Am J Ophthalmol 1954;37:13-14.
2. Gonzales-Jiminez E, Leopold IH. Effects of dichlorphenamide on the intraocular pressure of humans. Arch Ophthalmol 1958;60:427-436.
3. Drance SM. The effects of ethoxzolamide (Cardrase) on intraocular pressure. Arch Ophthalmol 1959;62:679-684.
4. Lichter PR, Newman LP, Wheeler NC, et al. Patient tolerance to carbonic anhydrase inhibitors. Am J Ophthalmol 1978;85:495-502.
5. Epstein DL, Grant WM. Carbonic anhydrase inhibitor side effects. Arch Ophthalmol 1977;95:1378-1382.
6. Wallace TR, Fraunfelder FT, Petursson GJ, et al. Decreased libido - a side effect of carbonic anhydrase inhibitor. Ann Ophthalmol 1979;11:1563-1566.
7. Mogk LG, Cyrlin MN. Blood dyscrasias and carbonic anhydrase inhibitors. Ophthalmology 1988;95:768-771.
8. Maren TH. Teratology and carbonic anhydrase inhibition. Arch Ophthalmol 1971;85:16-17.
9. Gelatt KN, Gum GG, Williams LW, et al. Ocular hypotensive effects of carbonic anhydrase inhibitors in normotensive and glaucomatous Beagles. Am J Vet Res 1979;40:334-345.
10. Gum GG. Physiology of the eye. In: Veterinary ophthalmology. 2nd ed. Philadelphia: Lea & Febiger, 1991;124-161.
11. Lippa EA, Carlson L, Ehinger B, et al. Dose response and duration of action of dorzolamide, a topical carbonic anhydrase inhibitor. Arch Ophthalmol 1992;110:495-499
12. Wilkerson M, Cyrlin M, Lippa EA, et al. Four-week safety and efficacy study of dorzolamide, a novel, active topical carbonic anhydrase inhibitor. Arch Ophthalmol 1993;111:1343-1350.
13. Simpson AJ, Gray TB, Ballantyne C. A controlled clinical trial of dorzolamide: a single-centre subset of a multicentre study. Aust N Z J Ophthalmol 1996;24:39-42.
14. Le HH, Chang MR, Cheng Q, et al. The effectiveness and safety of dorzolamide 2% in addition to multiple topical antiglaucoma medications. J Ocul Pharmacol Ther 1999;15:305-312.
15. Yamazaki Y, Miyamoto S, Sawa M. Effect of MK-507 on aqueous humor dynamics in normal human eyes. Jpn J Ophthalmol 1994;38:92-96.
16. Schmitz K, Banditt P, Motschmann M, et al. Population pharmacokinetics of 2% topical dorzolamide in the aqueous humor of humans. Invest Ophthalmol Vis Sci 1999;40:1621-1624.
17. Wang RF, Serie JB, Podos SM, et al. MK-507 (L-671,152), a topically active carbonic anhydrase inhibitor, reduces aqueous humor production in monkeys. Arch Ophthalmol 1991;109:1297-1299.
18. King TC, Gum GG, Gelatt KN. Evaluation of a topically administered carbonic anhydrase inhibitor (MK-927) in normotensive and glaucomatous Beagles. Am J Vet Res 1991;52:2067-2070.
19. Jones RF, Maurice DM. New methods of measuring the rate of aqueous flow in man with fluorescein. Exp Eye Res 1966;5:208-220.
20. Yablonski ME, Zimmerman TJ, Waltman SR, et al. A fluorophotometric study of the effect of topical timolol on aqueous humor dynamics. Exp Eye Res 1978;27:135-142.
21. Bloom JN, Levene RZ, Thomas G, et al. Fluorophotometry and the rate of aqueous flow in man: I. Instrumentation and normal values Arch Ophthalmol 1976;94:435-443.
22. Coakes RL. Slit-lamp fluorophotometry of the anterior segment. Trans Ophthalmol Soc U K 1981;101:149-151.
23. Cunha-vaz J. Ocular fluorophotometry: standardization and instrumentation development. Int Ophthalmol 1993;17:147-153.
24. Ward DA, Cawrse MA, Hendrix DVH. Fluorophotometric determination of aqueous humor flow rate in clinically normal Beagles. Am J Vet Res 2001;62:853-858.
25. Miller PE, Nelson MJ, Rhaesa SL. Effects of topical administration of 0.5% apraclonidine on intraocular pressure, pupil size, and heart rate in clinically normal dogs. Am J Vet Res 1996;57:79-82.
26. Wistrand PJ, Schenholm M, Lönnerholm G. Carbonic anhydrase isoenzymes CA I and CA II in the human eye. Invest Ophthalmol Vis Sci 1986;27:419-428.
27. van Best JA, Boets EPM, Stolwijk TR. Simultaneous determination of corneal endothelial permeability value and anterior chamber flow. In: Cunha-vaz JG, Leite E, Raymos MC, eds. Manual of ocular fluorometry. Coimbra, Portugal: Coimbra, 1993;51-67.
28. Peiffer RL Jr, Gelatt KN, Gum GG. Determination of the facility of aqueous humor outflow in the dog, comparing in vivo and in vitro tonographic and constant pressure perfusion techniques. Am J Vet Res 1976;73:1473-1477.
29. Brubaker RF. Clinical evaluation of the circulation of aqueous humor. In: Duane's clinical ophthalmology. Philadelphia: JB Lippincott Co, 1992;3:1-11.